Diabetes Therapy

, Volume 9, Issue 2, pp 663–663 | Cite as

Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study

  • Jelica Bjekić-Macut
  • Teodora Beljić Živković
  • Radivoj Kocić
Open Access
Author Correction
  • 155 Downloads

Author Correction to: Diabetes Ther  https://doi.org/10.1007/s13300-018-0378-4

In the original publication, values of the doses of insulin glargine, the most commonly used basal insulin analogue under the ‘Discussion’ section was incorrectly published.

The sentence “…was similar (3100.314 ± 110.1298 U/kg body weight/day at baseline) to that in the Swedish study (0.33 ± 0.16 U/kg body weight/day)”.

Should actually say “…was similar (0.31 ± 0.12 U/kg body weight/day at baseline) to that in the Swedish study (0.33 ± 0.16 U/kg body weight/day)”.

Notes

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright information

© The Author(s) 2018

Authors and Affiliations

  1. 1.Belgrade School of Medicine, Bezanijska Kosa University Medical Center, Division of Endocrinology, Diabetes and Metabolic disordersUniversity of BelgradeBelgradeSerbia
  2. 2.Belgrade School of Medicine, “Zvezdara” University Medical Center, Division of Endocrinology, Diabetes and Metabolic disordersUniversity of BelgradeBelgradeSerbia
  3. 3.Clinic for Endocrinology, Faculty of MedicineUniversity of NisNisSerbia

Personalised recommendations